Bio-Rad Laboratories | BIO - Interest Expense On Debt


Bio-Rad Laboratories reported $12.1M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Agilent USD 29M 4M Jun/2026
Becton, Dickinson and Co. USD 130M 2M Sep/2026
Bio Techne USD 2.17M 1.43M Sep/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Charles River Laboratories USD 28.52M 1.82M Sep/2026
Danaher USD 135M 28M Sep/2026
General Electric Aerospace USD 231M 265M Sep/2026
Illumina USD 24M 0 Sep/2026
IQVIA Holdings USD 203M 6M Sep/2026
Laboratory Of America USD 59.1M 2M Sep/2026
Merck USD 525M 46M Jun/2026
Mettler Toledo International USD 15.68M 1.57M Sep/2026
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quest Diagnostics USD 61M 8M Sep/2026
Repligen USD 5.71M 49K Sep/2026
Revvity USD 20.81M 2.18M Sep/2026
Roche Holding CHF 304M 7.5M Jun/2025
Siemens EUR 377M 6M Sep/2026
Standard Biotools USD 5K 5K Dec/2025
Thermo Fisher Scientific USD 417M 63M Sep/2026
Tosoh JPY 884M 65M Sep/2025
Waters USD 53M 2M Sep/2026